Washington Examiner
Sign in Subscribe
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Tags › Posts tagged Pharmaceutical Industry

Tag: Pharmaceutical Industry

Walgreens confirmed Tuesday that it will buy rival Rite Aid, creating a drugstore giant with nearly 18,000 stores around the world. (AP Photo/Charles Krupa, File) Business

Walgreens and Rite Aid deal could impact drug prices

Robert King · October 28, 2015 5:51 pm
While there's still a deep partisan divide over Obamacare, more poll respondents are basing their views on personal experience with the law's provisions. (AP Photo) Healthcare

Americans deeply worried about healthcare costs

Paige Winfield Cunningham · October 28, 2015 3:42 pm
A poll released Wednesday from the Kaiser Family Foundation found that 89 percent of those surveyed want the Food and Drug Administration to review drug ads before they air. (Screenshot) Healthcare

Americans want more regulation of TV drug ads

Robert King · October 28, 2015 3:30 pm
Healthcare

Budget deal targets high drug prices

Robert King · October 27, 2015 7:36 pm
The Iron Sheik, a beloved villain in the WWE, called out Martin Shkreli, the CEO of Turing Pharmaceuticals, with colorful language on Twitter on Monday. (AP Photo) Healthcare

Iron Sheik challenges CEO to wrestling match over drug prices

Robert King · October 26, 2015 10:23 pm
The new smart drug could be particularly useful for ensuring the mentally ill continue taking their medications, not just by just giving doctors a way to monitor their behavior, but courts as well. (AP photo)  Healthcare

New ‘smart’ drugs tell doctor you’re not taking them

Paige Winfield Cunningham · October 26, 2015 4:01 am
Imprimis said Thursday it would make a formulation of Daraprim for $1 a pill, or $99 for a 100-count bottle. Daraprim's maker, Turing Pharmaceuticals, jacked up the price of the treatment from $13.50 a pill to $750. (Courtesy of Joel Morillo of Passage Productions via AP) Healthcare

Pharmacies skirt regs to compete against high prices

Robert King · October 25, 2015 4:01 am
Imprimis to offer competitor after outrage over 5,000-percent price hike for anti-parasite treatment. (AP Photo/Rich Pedroncelli) Healthcare

Company offers $1 alternative to $750 drug

Robert King · October 22, 2015 6:29 pm
Valeant Pharmaceuticals Inc. said late Wednesday that federal prosecutors are seeking information on the drug developer's drug pricing, distribution and patient assistance program. (Ryan Remiorz/The Canadian Press via AP, File) Healthcare

Wall Street smacks drug maker under federal investigaton

Robert King · October 21, 2015 6:44 pm
Hillary pretends drugmakers, insurers are her enemies Columnists

Hillary pretends drugmakers, insurers are her enemies

Timothy P. Carney · October 20, 2015 10:50 pm
Democratic presidential candidate Hillary Clinton wrote to the FDA and the Federal Trade Commission about the anti-parasite drug Daraprim. (AP Photo/Mary Schwalm) Healthcare

Clinton demands regulators target drug maker

Robert King · October 19, 2015 3:04 pm
Prices on generic drugs are getting outrageously expensive as the FDA meddles in the market -- and unfortunately, they almost never come down again.  Healthcare

Generic drug prices go up, up, up

Carla Kalogeridis · October 19, 2015 4:01 am
Advertisement
  • ‹Previous page
  • 1
  • …
  • 121
  • 122
  • 123
  • 124
  • 125
  • …
  • 142
  • ›Next page
Page 123 of 142
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement